Advertisement
Screener

Nautilus Biotechnology, Inc. (NAUT) Public Float

2.8 / 5 stars · 68/120 Roast Me

Nautilus Biotechnology, Inc. Public Float

Nautilus Biotechnology, Inc. (NAUT) had Public Float of $35.80 million as of 2025-06-30, per its 10-K filed 2026-02-26.

Financial Statements › Notes › Cover Page

dei:EntityPublicFloat · last filed 2026-02-26

  • 2025-06-30: Entity Public Float $35.80M.
  • 2024-06-30: Entity Public Float $113.00M.
  • 2023-06-30: Entity Public Float $219.00M.
  • 2022-06-30: Entity Public Float $152.00M.
Period endEntity Public Float
2025-06-30$35.80M
10-K · filed 2026-02-26
2024-06-30$113.00M
10-K · filed 2025-02-27
2023-06-30$219.00M
10-K · filed 2024-02-28
2022-06-30$152.00M
10-K · filed 2023-02-23
2021-06-30$571.00M
10-K · filed 2022-02-24
2020-06-30$167.62M
10-K · filed 2021-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quanterix Corp (QTRX)United States$0.150B-1.65
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15